Fig. 4From: Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and intensity-modulated radiation therapy for prostate cancerBiochemical recurrence-free rate of the LDR-BT group stratified by biologically effective dose (BED) using the definition of PSA ≥ 0.2 ng/mLBack to article page